Does OLMESARTAN MEDOXOMIL Cause Impaired gastric emptying? 144 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Impaired gastric emptying have been filed in association with OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL). This represents 1.2% of all adverse event reports for OLMESARTAN MEDOXOMIL.
144
Reports of Impaired gastric emptying with OLMESARTAN MEDOXOMIL
1.2%
of all OLMESARTAN MEDOXOMIL reports
4
Deaths
113
Hospitalizations
How Dangerous Is Impaired gastric emptying From OLMESARTAN MEDOXOMIL?
Of the 144 reports, 4 (2.8%) resulted in death, 113 (78.5%) required hospitalization.
Is Impaired gastric emptying Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN MEDOXOMIL. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN MEDOXOMIL Cause?
Sprue-like enteropathy (3,482)
Gastrooesophageal reflux disease (1,819)
Acute kidney injury (1,587)
Weight decreased (1,569)
Haemorrhoids (1,316)
Diarrhoea (1,300)
Hiatus hernia (938)
Dizziness (885)
Large intestine polyp (839)
Constipation (796)
What Other Drugs Cause Impaired gastric emptying?
SEMAGLUTIDE (2,622)
DULAGLUTIDE (1,301)
TIRZEPATIDE (1,026)
ADALIMUMAB (296)
LIRAGLUTIDE (292)
ETANERCEPT (223)
METHOTREXATE (220)
INFLIXIMAB (219)
RITUXIMAB (219)
CYCLOSPORINE (213)
Which OLMESARTAN MEDOXOMIL Alternatives Have Lower Impaired gastric emptying Risk?
OLMESARTAN MEDOXOMIL vs OLMETEC
OLMESARTAN MEDOXOMIL vs OLODATEROL
OLMESARTAN MEDOXOMIL vs OLODATEROL\TIOTROPIUM
OLMESARTAN MEDOXOMIL vs OLOPATADINE
OLMESARTAN MEDOXOMIL vs OLUTASIDENIB